These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31909004)

  • 21. Digital Subtraction Angiography-Guided Foam Sclerotherapy with Polidocanol for Treating Superficial Venous Malformation.
    Anh TT; Nguyen QL; Thi QM; Minh TP
    Ann Vasc Dis; 2021 Sep; 14(3):231-235. PubMed ID: 34707744
    [No Abstract]   [Full Text] [Related]  

  • 22. Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children - A retrospective cohort study from a single tertiary medical center.
    Hou F; Chen J; Xia M; Ding K; Zeng Q; Liu W
    Medicine (Baltimore); 2020 Feb; 99(9):e18839. PubMed ID: 32118707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Controlled sclerosing in the treatment of venous maxillofacial malformations].
    Grishin AA; Durdyev OS; Smyslenova MV; Drobyshev AY
    Stomatologiia (Mosk); 2019; 98(4):60-64. PubMed ID: 31513152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial.
    Moser KH; Mosch C; Walgenbach M; Bussen DG; Kirsch J; Joos AK; Gliem P; Sauerland S
    Int J Colorectal Dis; 2013 Oct; 28(10):1439-47. PubMed ID: 23775099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injection sclerotherapy for varicose veins.
    de Ávila Oliveira R; Riera R; Vasconcelos V; Baptista-Silva JC
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD001732. PubMed ID: 34883526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sclerotherapy with radio-opaque foam guided by digital subtraction angiography for the treatment of complex venous malformations of the head and neck.
    Chen AW; Liu YR; Li K; Zhang K; Wang T; Liu SH
    Br J Oral Maxillofac Surg; 2015 Nov; 53(9):809-13. PubMed ID: 26113044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical results of polidocanol sclerotherapy in venous malformation treatment: Patient-perceived improvement and satisfaction.
    Çay F; Altunbulak AY; Özbay Y; Eldem G; Çil BE; Vargel İ; Kutluk MT; Yalçın B; Peynircioğlu B
    Phlebology; 2023 Feb; 38(1):36-43. PubMed ID: 36433742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sclerotherapy in venous malformation.
    Rabe E; Pannier F
    Phlebology; 2013 Mar; 28 Suppl 1():188-91. PubMed ID: 23482557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Foam sclerotherapy for a symptomatic hepatic cyst: a preliminary report.
    Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):800-4. PubMed ID: 24170168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
    Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
    Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lauromacrogol foam injection under ultrasonic guidance for pediatric lip venous malformations.
    Li K; Jiang Y; Wei Z; Chang J; Jinqiao L; Yongqi L; Zhou B; Sheng X
    Pediatr Surg Int; 2023 Jan; 39(1):93. PubMed ID: 36705764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sonographically guided percutaneous sclerosis using 1% polidocanol in the treatment of vascular malformations.
    Jain R; Bandhu S; Sawhney S; Mittal R
    J Clin Ultrasound; 2002 Sep; 30(7):416-23. PubMed ID: 12210459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound- and fluoroscopy-guided foam sclerotherapy for lower extremity venous ulcers.
    Zhu Y; Wu D; Sun D; Song K; Li J; Lin J
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):783-788. PubMed ID: 31917182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Foam Sclerotherapy in the Treatment of Hemangiomas and Venous Malformations.
    Yang C; Li M; Li X; Zhu J; Shu C
    Dermatol Surg; 2023 Sep; 49(9):855-861. PubMed ID: 37432998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasound-guided polidocanol foam sclerotherapy for symptomatic giant hepatic cyst: A single-center experience.
    Eso Y; Shimizu H; Takai A; Takahashi K; Seno H
    Hepatol Res; 2022 Jun; 52(6):557-565. PubMed ID: 35355375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A nomogram for predicting sclerotherapy response for treatment of lymphatic malformations in children.
    Wu Z; Zou Y; Fu R; Jin P; Yuan H
    Eur J Med Res; 2022 Oct; 27(1):209. PubMed ID: 36271467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment for telangiectasias and reticular veins.
    Nakano LC; Cacione DG; Baptista-Silva JC; Flumignan RL
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD012723. PubMed ID: 34637138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial.
    Gallo G; Picciariello A; Pietroletti R; Novelli E; Sturiale A; Tutino R; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Realis Luc A; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; D'Andrea V; Lobascio P
    Colorectal Dis; 2023 Mar; 25(3):386-395. PubMed ID: 36268758
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.